Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Bootstrap gate driver
Method and system for triggering message waiting indicator delivery
Fan guide
Liquid-filled protein-phosphatidic acid capsule dispersions
Bipolar junction transistor with a self-aligned emitter and base
Personalized health communication system
Resolution setting apparatus, resolution setting method, and recording medium recording a resolution setting program when a television is used as a monitor of a computer
  Randomly Featured Patents
Compounds having lysophosphatidic acid receptor antagonism and uses thereof
Method for producing a reduction product using a photo-regenerated transition metal catalyst
ATM switching arrangement
Process for producing microporous powders and membranes
Apparatus and method for training a baseball pitcher
Highly efficient transistor for fast programming of flash memories
Current mirror compensation using channel length modulation
Light-stabilized ink composition
Joint, a laminate, and a method of preparing a nickel-titanium alloy member surface for bonding to another layer of metal
Durable, high quality, portable sound system mounting kit